Finding of <i>O</i>-mannosyl Glycan in Mammals and Congenital Muscular Dystrophies due to Glycosylation Defects

DOI Web Site Web Site PubMed 2 Citations 69 References
  • ENDO Tamao
    <i>Glycobiology Research Group, Tokyo Metropolitan Institute of Gerontology, Foundation for Research on Aging and Promotion of Human Welfare</i>

Bibliographic Information

Other Title
  • <i>O</i>-マンノシル型糖鎖とその異常による先天性筋ジストロフィー
  • O-マンノシル型糖鎖とその異常による先天性筋ジストロフィー
  • O マンノシルガタ トウサ ト ソノ イジョウ ニ ヨル センテンセイ キンジストロフィー

Search this article

Abstract

Most proteins within living organisms contain glycans. Glycan structures can modulate the biological properties and function of glycoproteins. Developments in glycobiology have revealed a new type of glycosidic linkage to the peptide portion, the O-mannosyl linkage in mammals, although heretofore it had been thought to be specific to yeast. One of the best known O-mannosyl-modified glycoproteins is dystroglycan, which is a central component of dystrophin-glycoprotein complex isolated from skeletal muscle membranes. We identify and characterize a glycosyltransferase, UDP-N-acetylglucosamine: protein O-mannose β1,2-N-acetylglucosaminyltransferase (POMGnT1), involved in the biosynthesis of mammalian type O-mannosyl glycans. Finally, we find that the POMGnT1 gene is responsible for muscle-eye-brain disease (MEB). MEB is an autosomal recessive disorder characterized by congenital muscular dystrophy, ocular abnormalities and brain malformation (type II lissencephaly). Like MEB, recent data suggest that the aberrant protein glycosylation of a specific glycoprotein, α-dystroglycan, is the primary cause of some forms of congenital muscular dystrophy. Here I review the new insight into glycobiology of muscular dystrophy and neuronal migration disorder.<br>

Journal

  • YAKUGAKU ZASSHI

    YAKUGAKU ZASSHI 123 (10), 825-835, 2003-10-01

    The Pharmaceutical Society of Japan

Citations (2)*help

See more

References(69)*help

See more

Keywords

Details 詳細情報について

Report a problem

Back to top